Skip to main content
NANO MRNA Co.,Ltd. logo

NANO MRNA Co.,Ltd. — Investor Relations & Filings

Ticker · 4571 ISIN · JP3651120002 LEI · 529900L2VA2GIFZQTG17 T Professional, scientific and technical activities
Open in API
Filings indexed 70 across all filing types
Latest filing 2023-06-30 Governance Information
Country JP Japan
Listing T 4571

About NANO MRNA Co.,Ltd.

https://www.nanomrna.co.jp/

NANO MRNA Co., Ltd. is a biotechnology firm that operates as a platform company and an IP Generator specializing in mRNA-based medicine. The company focuses on creating and out-licensing intellectual property for novel therapeutics by connecting drug discovery seeds with medical and development needs. It leverages a proprietary drug delivery system (DDS) based on micellar nanoparticle technology to advance its pipeline. Key clinical programs include an mRNA therapy for osteoarthritis (RUNX1 mRNA) and an antisense oligonucleotide (ASO) for glioblastoma (TUG1 ASO). Evolving from its predecessor, NanoCarrier, the company combines a legacy of R&D in nanoparticle technology with a strategic focus on RNA drug discovery. It also co-developed and markets Comlex®, an antibacterial agent for ear, nose, and throat conditions.

Recent filings

Filing Released Lang Actions
内部統制報告書－第27期(2022/04/01－2023/03/31)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act of Japan. It details the company's framework, scope, and evaluation results regarding internal controls over financial reporting. This type of regulatory filing, which is distinct from a full Annual Report (10-K) or a simple announcement, falls under the category of Audit Report / Information (AR) as it pertains to the assessment of internal control systems and audit-related compliance.
2023-06-30 Japanese
有価証券報告書－第27期(2022/04/01－2023/03/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K. It contains detailed financial statements, management discussion, and corporate information for the fiscal year ending March 31, 2023. It is a comprehensive annual filing submitted to the Kanto Local Finance Bureau. FY 2023
2023-06-30 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically related to the accuracy of the 3rd Quarter Report. While it references a quarterly report, the document itself is a formal regulatory filing confirming the accuracy of the financial statements, which falls under the category of regulatory filings or audit-related compliance documentation. Given the specific nature of the filing as a regulatory confirmation, 'RNS' is the most appropriate fallback category.
2023-02-14 Japanese
四半期報告書－第27期第3四半期(2022/10/01－2022/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '第３四半期報告書' (Quarterly Report) for NanoCarrier Co., Ltd., covering the period from October 1, 2022, to December 31, 2022. It contains detailed financial statements, management analysis, and business updates, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-02-14 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-8 of the Financial Instruments and Exchange Act of Japan, which accompanies a Quarterly Report (Shihanki Hokokusho). Since the document is a formal regulatory filing confirming the accuracy of the quarterly report and is not the quarterly report itself, it falls under the category of general regulatory filings.
2022-11-11 Japanese
四半期報告書－第27期第2四半期(令和4年7月1日－令和4年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for NanoCarrier Co., Ltd., covering the second quarter of the 27th fiscal period (July 1, 2022, to September 30, 2022). It contains detailed financial statements, including the balance sheet, income statement, and cash flow statement, as well as management analysis. This fits the definition of an Interim/Quarterly Report (IR). Q2 2023
2022-11-11 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.